ADAPY
Adaptimmune Therapeutics PLC
-0.00 (-4.40%)0.02USD18.5K成交股數38.0M市值–本益比(近四季)0.6股價營收比-89.3%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-02 | 09-03 | Wood Gavin | Chief Financial Officer | S 公開市場賣出 | 96.0K | 0.01 | 960.00 | 0 | SEC |
| 2025-08-28 | 08-29 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 207K | 0.01 | 2K | 986K | SEC |
| 2025-08-18 | 08-19 | Behbahani Ali | Director | S 公開市場賣出 | 14.7M | 0.01 | 147K | 0 | SEC |
| 2025-08-15 | 08-19 | Behbahani Ali | Director | S 公開市場賣出 | 4.8M | 0.01 | 48K | 14.7M | SEC |
| 2025-07-30 | 07-30 | EcoR1 Capital, LLC | TenPercentOwner | S 公開市場賣出 | 27.4M | 0.10 | 2.7M | 100M | SEC |
| 2025-07-29 | 07-30 | EcoR1 Capital, LLC | TenPercentOwner | S 公開市場賣出 | 2.7M | 0.10 | 269K | 128M | SEC |
| 2025-07-28 | 07-30 | EcoR1 Capital, LLC | TenPercentOwner | S 公開市場賣出 | 33.9M | 0.11 | 3.7M | 130M | SEC |
| 2025-01-17 | 01-17 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 5.6K | 0.58 | 3K | 7.5K | SEC |
| 2025-01-17 | 01-17 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 5.6K | 0.58 | 3K | 7.5K | SEC |
| 2025-01-17 | 01-17 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 30.6K | 0.58 | 18K | 44.3K | SEC |
| 2025-01-17 | 01-17 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 5.6K | 0.58 | 3K | 7.5K | SEC |
| 2025-01-15 | 01-15 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 29.1K | 0.57 | 17K | 41.6K | SEC |
| 2025-01-15 | 01-15 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 9.8K | 0.57 | 6K | 13.8K | SEC |
| 2025-01-15 | 01-15 | Piccina Cintia | Chief Commercial Officer | S 公開市場賣出 | 13.0K | 0.57 | 7K | 18.4K | SEC |
| 2025-01-15 | 01-15 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 9.8K | 0.57 | 6K | 13.8K | SEC |
| 2025-01-15 | 01-15 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 9.8K | 0.57 | 6K | 13.8K | SEC |
| 2025-01-13 | 01-15 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 4.3K | 0.59 | 3K | 5.8K | SEC |
| 2025-01-13 | 01-15 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 5.5K | 0.59 | 3K | 7.6K | SEC |
| 2025-01-13 | 01-15 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 4.3K | 0.59 | 3K | 5.8K | SEC |
| 2025-01-13 | 01-15 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 17.9K | 0.59 | 11K | 25.7K | SEC |
| 2025-01-13 | 01-15 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 12.5K | 0.59 | 7K | 17.8K | SEC |
| 2025-01-13 | 01-15 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 8.1K | 0.59 | 5K | 11.5K | SEC |
| 2025-01-13 | 01-15 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 5.5K | 0.59 | 3K | 7.6K | SEC |
| 2025-01-13 | 01-15 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 4.3K | 0.59 | 3K | 5.8K | SEC |
| 2024-06-18 | 06-18 | Piccina Cintia | Chief Commercial Officer | S 公開市場賣出 | 24.5K | 0.93 | 23K | 38.3K | SEC |
| 2024-01-17 | 01-17 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 5.3K | 0.67 | 4K | 7.8K | SEC |
| 2024-01-17 | 01-17 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 13.6K | 0.67 | 9K | 20.2K | SEC |
| 2024-01-17 | 01-17 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 5.3K | 0.67 | 4K | 7.8K | SEC |
| 2024-01-17 | 01-17 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 30.1K | 0.67 | 20K | 44.8K | SEC |
| 2024-01-17 | 01-17 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 12.8K | 0.67 | 9K | 19.0K | SEC |
| 2024-01-17 | 01-17 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 13.0K | 0.67 | 9K | 19.3K | SEC |
| 2024-01-17 | 01-17 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 5.3K | 0.67 | 4K | 7.8K | SEC |
| 2024-01-16 | 01-17 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 4.7K | 0.79 | 4K | 7.0K | SEC |
| 2024-01-16 | 01-17 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 9.3K | 0.79 | 7K | 14.1K | SEC |
| 2024-01-16 | 01-17 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 2.3K | 0.79 | 2K | 3.4K | SEC |
| 2024-01-16 | 01-17 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 4.7K | 0.79 | 4K | 7.0K | SEC |
| 2024-01-12 | 01-12 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 5.2K | 0.85 | 4K | 7.9K | SEC |
| 2024-01-12 | 01-12 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 5.2K | 0.85 | 4K | 7.9K | SEC |
| 2024-01-12 | 01-12 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 7.8K | 0.85 | 7K | 11.8K | SEC |
| 2024-01-12 | 01-12 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 17.3K | 0.85 | 15K | 26.4K | SEC |
| 2024-01-11 | 01-12 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 4.0K | 0.84 | 3K | 6.1K | SEC |
| 2024-01-11 | 01-12 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 11.9K | 0.84 | 10K | 18.4K | SEC |
| 2024-01-11 | 01-12 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 4.0K | 0.84 | 3K | 6.1K | SEC |
| 2024-01-11 | 01-12 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 4.0K | 0.84 | 3K | 6.1K | SEC |
| 2023-09-01 | 09-01 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 2.4K | 0.78 | 2K | 3.4K | SEC |
| 2023-08-01 | 08-01 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 3.1K | 0.91 | 3K | 4.7K | SEC |
| 2023-07-10 | 07-10 | Menzel Garry E | Director | S 公開市場賣出 | 47.7K | 0.91 | 43K | 75.1K | SEC |
| 2023-06-27 | 06-27 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 2.3K | 0.92 | 2K | 3.5K | SEC |
| 2023-06-01 | 06-01 | Menzel Garry E | Director | A 獲配股票 | 201K | – | – | 201K | SEC |
| 2023-06-01 | 06-01 | Menzel Garry E | Director | A 獲配股票 | 201K | – | – | 201K | SEC |
| 2023-06-01 | 06-01 | Menzel Garry E | Director | A 獲配股票 | 210K | – | – | 210K | SEC |
| 2023-01-31 | 01-31 | Piccina Cintia | Chief Commercial Officer | S 公開市場賣出 | 11.9K | 1.87 | 22K | 19.5K | SEC |
| 2023-01-17 | 01-17 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 2.2K | 1.86 | 4K | 3.5K | SEC |
| 2023-01-17 | 01-17 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 10.1K | 1.86 | 19K | 13.4K | SEC |
| 2023-01-17 | 01-17 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 4.4K | 1.86 | 8K | 7.3K | SEC |
| 2023-01-17 | 01-17 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 4.4K | 1.86 | 8K | 7.3K | SEC |
| 2023-01-12 | 01-12 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 18.8K | 1.71 | 32K | 24.9K | SEC |
| 2023-01-12 | 01-12 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 7.4K | 1.71 | 13K | 12.2K | SEC |
| 2023-01-12 | 01-12 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 5.0K | 1.71 | 9K | 8.1K | SEC |
| 2023-01-12 | 01-12 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 5.0K | 1.71 | 9K | 8.1K | SEC |
| 2023-01-11 | 01-12 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 3.8K | 1.75 | 7K | 6.3K | SEC |
| 2023-01-11 | 01-12 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 3.8K | 1.75 | 7K | 6.3K | SEC |
| 2023-01-11 | 01-12 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 3.8K | 1.75 | 7K | 6.3K | SEC |
| 2023-01-11 | 01-12 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 13.0K | 1.75 | 23K | 17.3K | SEC |
| 2023-01-04 | 01-04 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 1.1K | 1.69 | 2K | 1.7K | SEC |
| 2023-01-04 | 01-04 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 876 | 1.69 | 1K | 1.4K | SEC |
| 2023-01-04 | 01-04 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 5.1K | 1.69 | 9K | 6.6K | SEC |
| 2023-01-04 | 01-04 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 3.6K | 1.69 | 6K | 5.8K | SEC |
| 2022-09-01 | 09-01 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 2.5K | 1.97 | 5K | 3.3K | SEC |
| 2022-08-01 | 08-01 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 3.0K | 1.77 | 5K | 4.8K | SEC |
| 2022-08-01 | 08-01 | Piccina Cintia | Chief Commercial Officer | S 公開市場賣出 | 21.0K | 1.77 | 37K | 34.8K | SEC |
| 2022-07-05 | 07-05 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 2.0K | 1.68 | 3K | 3.1K | SEC |
| 2022-06-27 | 06-27 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 2.6K | 1.63 | 4K | 3.3K | SEC |
| 2022-05-20 | 05-23 | Wood Gavin | Chief Financial Officer | P 公開市場買進 | 39.0K | 0.29 | 11K | 96.0K | SEC |
| 2022-01-18 | 01-18 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 11.1K | 3.19 | 35K | 12.3K | SEC |
| 2022-01-18 | 01-18 | Bertrand William C JR | Chief Operating Officer | S 公開市場賣出 | 4.4K | 3.19 | 14K | 7.3K | SEC |
| 2022-01-18 | 01-18 | Lunger John | Chief Patient Supply Officer | S 公開市場賣出 | 4.4K | 3.19 | 14K | 7.3K | SEC |
| 2022-01-18 | 01-18 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 2.1K | 3.19 | 7K | 3.5K | SEC |
| 2022-01-12 | 01-13 | Rawcliffe Adrian | Chief Executive Officer | S 公開市場賣出 | 3.0K | 3.54 | 11K | 3.4K | SEC |
| 2022-01-12 | 01-13 | Norry Elliot | Chief Medical Officer | S 公開市場賣出 | 854 | 3.54 | 3K | 1.4K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-03-31
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RHUMBLINE ADVISERS | 3.7K | 72.00 | 不變 | 持平 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1 -9 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 0 / 9 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 3.7K · 0.0% |
| 合計季末市值 | 72.00 |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.2M |
|---|---|
| 與上期比 | 0.0% |
| 佔流通股數 | 0.08% |
| 日均成交量 | 298K |
| 回補天數 | 4.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.2M | 0.0% | 0.08% | 298K | 4.1 |
| 2026-08-14 | 1.2M | 0.0% | 0.08% | 220K | 5.6 |
| 2026-07-31 | 1.2M | 0.0% | 0.08% | 728K | 1.7 |
| 2026-07-15 | 1.2M | 0.0% | 0.08% | 1.1M | 1.1 |
| 2026-06-30 | 1.2M | 0.0% | 0.08% | 787K | 1.6 |
| 2026-06-15 | 1.2M | -45.4% | 0.08% | 2.0M | 1.0 |
| 2026-05-29 | 2.2M | 0.0% | 0.14% | 216K | 10.3 |
| 2026-05-15 | 2.2M | -0.7% | 0.14% | 862K | 2.6 |
| 2026-04-30 | 2.2M | +82.0% | 0.14% | 793K | 2.8 |
| 2026-04-15 | 1.2M | 0.0% | 0.08% | 652K | 1.9 |
| 2026-03-31 | 1.2M | +0.0% | 0.08% | 402K | 3.1 |
| 2026-03-13 | 1.2M | 0.0% | 0.08% | 451K | 2.7 |
| 2026-02-27 | 1.2M | +0.0% | 0.08% | 1.5M | 1.0 |
| 2026-02-13 | 1.2M | -0.8% | 0.08% | 851K | 1.5 |
| 2026-01-30 | 1.2M | -29.9% | 0.08% | 1.9M | 1.0 |
| 2026-01-15 | 1.8M | -13.5% | 0.11% | 3.6M | 1.0 |
| 2025-12-31 | 2.1M | -26.3% | 0.13% | 6.1M | 1.0 |
| 2025-12-15 | 2.8M | -17.0% | 0.17% | 2.8M | 1.0 |
| 2025-11-28 | 3.4M | -19.2% | 0.21% | 8.2M | 1.0 |
| 2025-11-14 | 4.1M | -44.2% | 0.26% | 10.3M | 1.0 |
| 2025-10-31 | 7.4M | -76.3% | 0.47% | 120M | 1.0 |